Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00652197 · ClinicalTrials.gov registry record
Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor
A clinical trial, sponsored by Transonic Systems.
- Completed
- Registry status
- 16
- Enrollment target
NCT00652197 is a clinical trial that has completed, run by Transonic Systems. The registered enrollment target is 16 participants.
The verdict
NCT00652197 has completed, sponsored by Transonic Systems.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
Study Summary
The study hypothesis is that an ultrasonic flow sensor can accurately measure flow in hydrocephalic shunts. The ultrasonic sensor will measure cerebro-spinal fluid drainage in hydrocephalus patients with external ventriculostomies and extra-ventricular drainage systems. The sensor measurements will be compared with the volume of fluid collected by the drainage bag. After a 24-hour measurement period, the doctor will change the drainage bag position to simulate the patient sitting up and leaning back, to see if this temporarily stops flow through the drainage line. This data will show whether the sensor accurately measures typical drainage flows seen in hydrocephalus patients. This research will help develop an implantable flow monitor for pediatric hydrocephalus patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-03 |
| Est. Completion | 2014-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00652197
The ClinicalTrials.gov registry entry for NCT00652197 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Transonic Systems, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00652197 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00652197 about?
NCT00652197 is a clinical study titled "Monitoring Patient Cerebro-Spinal Fluid Drainage With an Ultrasonic Flow Sensor". The study hypothesis is that an ultrasonic flow sensor can accurately measure flow in hydrocephalic shunts. The ultrasonic sensor will measure cerebro-spinal fluid drainage in hydrocephalus patients with external ventriculostomies and extra-ventricular drainage systems. The sensor measurements will...
What is the current status of trial NCT00652197?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2009-03. Estimated completion is 2014-05.
Who is sponsoring clinical trial NCT00652197?
This trial is sponsored by Transonic Systems, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.